Holen Sie sich die Stockscreener-App
12.92
2.78%
0.35
Handel nachbörslich:
13.00
0.08
+0.62%
Roivant Sciences Ltd Aktie (ROIV) Neueste Nachrichten
Should I hold or sell Roivant Sciences Ltd. nowProfit Target & Capital Protection Trading Alerts - خودرو بانک
What is the cash position of Roivant Sciences Ltd.Market Sentiment Report & Real-Time Stock Price Movement Reports - خودرو بانک
Real time pattern detection on Roivant Sciences Ltd. stockJuly 2025 Opening Moves & Detailed Earnings Play Strategies - Newser
Is Roivant Sciences Ltd. stock undervalued right nowTrade Performance Summary & Growth Focused Entry Reports - خودرو بانک
Roivant Sciences Ltd. stock trend outlook and recovery pathWeekly Profit Recap & Stepwise Trade Signal Guides - Newser
Candlestick signals on Roivant Sciences Ltd. stock todayQuarterly Earnings Report & Safe Entry Point Alerts - Newser
Order flow analysis tools used on Roivant Sciences Ltd.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
Can Roivant Sciences Ltd. outperform in the next rallyJuly 2025 Weekly Recap & Weekly High Momentum Picks - خودرو بانک
What machine learning models say about Roivant Sciences Ltd.Portfolio Return Report & Long-Term Growth Plans - Newser
Tools to monitor Roivant Sciences Ltd. recovery probabilityWeekly Trend Report & Entry and Exit Point Strategies - Newser
Is Roivant Sciences Ltd. stock a good hedge against inflationJuly 2025 Retail & Risk Adjusted Buy/Sell Alerts - Newser
Is Roivant Sciences Ltd. stock bottoming outEarnings Recap Report & Weekly High Conviction Ideas - Newser
Combining price and volume data for Roivant Sciences Ltd.2025 Key Highlights & Consistent Return Investment Signals - Newser
Will Roivant Sciences Ltd. outperform the marketMarket Weekly Review & Safe Capital Growth Trade Ideas - Newser
Roivant Sciences stock hits 52-week high at 13.06 USD - Investing.com
How institutional ownership impacts Roivant Sciences Ltd. stockWeekly Risk Summary & Fast Exit/Entry Strategy Plans - Newser
Can swing trading help recover from Roivant Sciences Ltd. lossesIndex Update & Risk Controlled Swing Trade Alerts - Newser
Roivant Sciences' Mosliciguat Granted Orphan Drug Designation in Japan - MarketScreener
Pulmovant Receives Orphan Drug Designation in Japan for Mosliciguat for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) - GlobeNewswire Inc.
Signal Recap: How volatile is Roivant Sciences Ltd. stockJuly 2025 Pullbacks & Low Risk Investment Opportunities - خودرو بانک
Automated trading signals detected on Roivant Sciences Ltd.Quarterly Profit Report & Daily Entry Point Trade Alerts - Newser
How to build a custom watchlist for Roivant Sciences Ltd.Portfolio Performance Report & Long-Term Capital Growth Strategies - Newser
Should you hold or exit Roivant Sciences Ltd. nowIPO Watch & Long-Term Capital Growth Strategies - Newser
What candlestick patterns are forming on Roivant Sciences Ltd.July 2025 Fed Impact & Smart Investment Allocation Tips - Newser
Is Roivant Sciences Ltd. backed by strong institutional buying2025 Short Interest & Daily Entry Point Alerts - خودرو بانک
Transcript : Roivant Sciences Ltd.Special Call - MarketScreener
Forecasting Roivant Sciences Ltd. price range with options data2025 Breakouts & Breakdowns & Free Expert Verified Stock Movement Alerts - Newser
Will Roivant Sciences Ltd. see short term momentumMarket Sentiment Report & Real-Time Buy Signal Notifications - Newser
Using RSI to spot recovery in Roivant Sciences Ltd.July 2025 Pullbacks & Free Growth Oriented Trading Recommendations - Newser
Short interest data insights for Roivant Sciences Ltd.July 2025 Gainers & Free Real-Time Volume Trigger Notifications - Newser
Can Roivant Sciences Ltd. ride the EV waveQuarterly Trade Review & Weekly Stock Performance Updates - خودرو بانک
Technical analysis overview for Roivant Sciences Ltd. stock2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser
Is Roivant Sciences Ltd. forming a reversal patternEarnings Summary Report & AI Driven Stock Movement Reports - Newser
Will a bounce in Roivant Sciences Ltd. offer an exitJuly 2025 PreEarnings & Weekly High Momentum Picks - Newser
Roivant Sciences Ltd. stock daily chart insightsJuly 2025 Big Picture & High Accuracy Trade Signal Alerts - Newser
Citi Initiates Roivant Sciences(ROIV.US) With Buy Rating, Announces Target Price $16 - 富途牛牛
Roivant Sciences stock rating reiterated by TD Cowen ahead of trial data - Investing.com UK
Citigroup initiates coverage on Roivant Sciences with Buy rating and $16 price target. - AInvest
How to monitor Roivant Sciences Ltd. with trend dashboardsWeekly Market Report & Capital Efficiency Focused Ideas - Newser
Will Roivant Sciences Ltd. bounce back from current supportEarnings Recap Summary & Daily Entry Point Alerts - Newser
Trading Bots Trigger Alerts on Roivant Sciences Ltd. Activity getLinesFromResByArray error: size == 0 - thegnnews.com
How to use Fibonacci retracement on Roivant Sciences Ltd.Portfolio Return Report & Safe Entry Zone Identification - Newser
Analyzing Roivant Sciences Ltd. with risk reward ratio chartsJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - Newser
Chart overlay techniques for tracking Roivant Sciences Ltd.Stop Loss & Verified Stock Trade Ideas - Newser
Building trade automation scripts for Roivant Sciences Ltd.Global Markets & Proven Capital Preservation Tips - Newser
Identifying reversal signals in Roivant Sciences Ltd.July 2025 Fed Impact & AI Driven Price Forecasts - Newser
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):